医保目录-话题@MedSci

#医保目录#

80篇内容 | 1379人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2174713, encodeId=95b921e47130d, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=新版国家医保目录公布！唯择（阿贝西利片）率先实现早期和晚期乳腺癌人群医保双覆盖 , objectType=article, longId=804624, objectId=ca5c804624f5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679882284896_4754896.png, objectUrl=/article/show_article.do?id=ca5c804624f5, replyNumber=0, likeNumber=29, createdTime=2023-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ca5c804624f5, moduleTitle=新版国家医保目录公布！唯择（阿贝西利片）率先实现早期和晚期乳腺癌人群医保双覆盖 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca5c804624f5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1468486, encodeId=54ca1468486f7, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=部分药品年底调出医保目录？医保基金不够用了？官方回应, objectType=article, longId=733294, objectId=bc53e3329462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc53e3329462, replyNumber=0, likeNumber=40, createdTime=2022-07-28, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc53e3329462, moduleTitle=部分药品年底调出医保目录？医保基金不够用了？官方回应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc53e3329462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468485, encodeId=2400146848537, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=哪些药品有望进医保？2022年国家医保目录调整“划重点”, objectType=article, longId=729759, objectId=29a1e2975989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29a1e2975989, replyNumber=0, likeNumber=0, createdTime=2022-06-18, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29a1e2975989, moduleTitle=哪些药品有望进医保？2022年国家医保目录调整“划重点”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29a1e2975989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468483, encodeId=0d1b1468483ec, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=君实生物特瑞普利单抗新增两项适应症纳入国家医保目录, objectType=article, longId=221523, objectId=b747221523b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b747221523b7, replyNumber=0, likeNumber=40, createdTime=2021-12-05, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b747221523b7, moduleTitle=君实生物特瑞普利单抗新增两项适应症纳入国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b747221523b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468480, encodeId=4d62146848078, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=刚刚！2021版国家医保目录发布（附全部名单下载）, objectType=article, longId=221485, objectId=a06122148582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a06122148582, replyNumber=0, likeNumber=36, createdTime=2021-12-05, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a06122148582, moduleTitle=刚刚！2021版国家医保目录发布（附全部名单下载）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a06122148582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468482, encodeId=e0961468482bb, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=杨森中国又有4个创新药被纳入国家医保目录，6个产品成功续约, objectType=article, longId=217202, objectId=c93d21e20202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c93d21e20202, replyNumber=0, likeNumber=31, createdTime=2021-09-18, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c93d21e20202, moduleTitle=杨森中国又有4个创新药被纳入国家医保目录，6个产品成功续约, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c93d21e20202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468484, encodeId=aa0f1468484b6, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=淋巴瘤创新药佳罗华®进入2021年国家医保目录, objectType=article, longId=215654, objectId=a5a921565425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5a921565425, replyNumber=0, likeNumber=38, createdTime=2021-08-14, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5a921565425, moduleTitle=淋巴瘤创新药佳罗华®进入2021年国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5a921565425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468481, encodeId=0cfd1468481ab, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=海正药业海博麦布片成功纳入2021国家医保目录，开启国创降脂新时代, objectType=article, longId=211809, objectId=f06b2118095d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06b2118095d, replyNumber=0, likeNumber=34, createdTime=2021-05-27, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06b2118095d, moduleTitle=海正药业海博麦布片成功纳入2021国家医保目录，开启国创降脂新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f06b2118095d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468479, encodeId=d20b14684e956, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=新近进展传出：长三角将统一医保目录，招采或将联动！, objectType=article, longId=209504, objectId=16d92095045b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d92095045b, replyNumber=0, likeNumber=29, createdTime=2021-04-05, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d92095045b, moduleTitle=新近进展传出：长三角将统一医保目录，招采或将联动！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d92095045b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468478, encodeId=d4f714684e866, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！, objectType=article, longId=208138, objectId=ca0a2081382a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0a2081382a, replyNumber=0, likeNumber=28, createdTime=2021-03-09, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0a2081382a, moduleTitle=新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca0a2081382a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468477, encodeId=fada14684e79d, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录, objectType=article, longId=208008, objectId=22a520800864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22a520800864, replyNumber=0, likeNumber=42, createdTime=2021-03-08, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22a520800864, moduleTitle=治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22a520800864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468476, encodeId=713614684e684, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=先声重磅产品先必新进入医保目录竞逐千亿脑卒中市场, objectType=article, longId=205574, objectId=49192055e40d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49192055e40d, replyNumber=0, likeNumber=32, createdTime=2021-01-11, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49192055e40d, moduleTitle=先声重磅产品先必新进入医保目录竞逐千亿脑卒中市场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49192055e40d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468475, encodeId=7bc014684e582, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=详解医保目录调整调入药品不仅“物美”还应“价廉”, objectType=article, longId=199187, objectId=bc0519918e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0519918e5c, replyNumber=0, likeNumber=32, createdTime=2020-08-12, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0519918e5c, moduleTitle=详解医保目录调整调入药品不仅“物美”还应“价廉”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0519918e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468474, encodeId=1fa614684e43d, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=全面解析2020年医保目录调整工作方案6大亮点, objectType=article, longId=198832, objectId=ab45198832b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab45198832b4, replyNumber=0, likeNumber=37, createdTime=2020-08-07, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab45198832b4, moduleTitle=全面解析2020年医保目录调整工作方案6大亮点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab45198832b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468473, encodeId=2c8d14684e3f7, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=新一轮医保目录调整方案出炉：新冠、基药、集采等7类药品纳入, objectType=article, longId=198782, objectId=dde1198e8294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dde1198e8294, replyNumber=0, likeNumber=39, createdTime=2020-08-07, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dde1198e8294, moduleTitle=新一轮医保目录调整方案出炉：新冠、基药、集采等7类药品纳入, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dde1198e8294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468472, encodeId=ce3e14684e272, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=刚刚！国家医保局发文：新一轮医保目录调整来了, objectType=article, longId=198694, objectId=1b7a198694b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b7a198694b8, replyNumber=0, likeNumber=23, createdTime=2020-08-05, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b7a198694b8, moduleTitle=刚刚！国家医保局发文：新一轮医保目录调整来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b7a198694b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468471, encodeId=231814684e1e9, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=医保目录调整9月1日施行，乙类OTC保留！药品临床价值是重点考量因素, objectType=article, longId=198623, objectId=6d5419862361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d5419862361, replyNumber=0, likeNumber=37, createdTime=2020-08-04, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d5419862361, moduleTitle=医保目录调整9月1日施行，乙类OTC保留！药品临床价值是重点考量因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d5419862361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468470, encodeId=acff14684e0da, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=用于治疗慢阻肺的创新产品欧乐欣纳入国家医保目录, objectType=article, longId=184110, objectId=044218411052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044218411052, replyNumber=0, likeNumber=29, createdTime=2019-12-05, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044218411052, moduleTitle=用于治疗慢阻肺的创新产品欧乐欣纳入国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044218411052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468469, encodeId=b6ff146846935, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=礼来与和黄医药共同开发的爱优特®（呋喹替尼胶囊）纳入国家医保目录, objectType=article, longId=183821, objectId=288618382189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288618382189, replyNumber=0, likeNumber=37, createdTime=2019-12-01, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288618382189, moduleTitle=礼来与和黄医药共同开发的爱优特®（呋喹替尼胶囊）纳入国家医保目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=288618382189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1468468, encodeId=628c146846835, content=<a href='/topic/show?id=272833882d8' target=_blank style='color:#2F92EE;'>#医保目录#</a>, objectTitle=诺华心衰创新药经谈判纳入2019医保目录，报销比例**达90%, objectType=article, longId=183786, objectId=520e183e8673, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=520e183e8673, replyNumber=0, likeNumber=48, createdTime=2019-11-30, rootId=0, userName=juliusluan80, userId=f3aa6907492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=520e183e8673, moduleTitle=诺华心衰创新药经谈判纳入2019医保目录，报销比例**达90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=520e183e8673)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医保目录

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#乳腺癌# #医保目录#

新版国家医保目录公布！唯择（阿贝西利片）率先实现早期和晚期乳腺癌人群医保双覆盖

2023-12-13发表于上海

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

部分药品年底调出医保目录？医保基金不够用了？官方回应

2022-07-28

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

哪些药品有望进医保？2022年国家医保目录调整“划重点”

2022-06-18

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

君实生物特瑞普利单抗新增两项适应症纳入国家医保目录

2021-12-05

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

刚刚！2021版国家医保目录发布（附全部名单下载）

2021-12-05

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

杨森中国又有4个创新药被纳入国家医保目录，6个产品成功续约

2021-09-18

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

淋巴瘤创新药佳罗华®进入2021年国家医保目录

2021-08-14

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

海正药业海博麦布片成功纳入2021国家医保目录，开启国创降脂新时代

2021-05-27

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

新近进展传出：长三角将统一医保目录，招采或将联动！

2021-04-05

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！

2021-03-09

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录

2021-03-08

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

先声重磅产品先必新进入医保目录竞逐千亿脑卒中市场

2021-01-11

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

详解医保目录调整调入药品不仅“物美”还应“价廉”

2020-08-12

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

全面解析2020年医保目录调整工作方案6大亮点

2020-08-07

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

新一轮医保目录调整方案出炉：新冠、基药、集采等7类药品纳入

2020-08-07

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

刚刚！国家医保局发文：新一轮医保目录调整来了

2020-08-05

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

医保目录调整9月1日施行，乙类OTC保留！药品临床价值是重点考量因素

2020-08-04

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

用于治疗慢阻肺的创新产品欧乐欣纳入国家医保目录

2019-12-05

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

礼来与和黄医药共同开发的爱优特®（呋喹替尼胶囊）纳入国家医保目录

2019-12-01

juliusluan80 (审核中...)

前往app查看评论内容

#医保目录#

诺华心衰创新药经谈判纳入2019医保目录，报销比例**达90%

2019-11-30

科室
- - 订阅+
  - 更多科室
工具
服务